Jeffrey Peppercorn

18.1k total citations · 5 hit papers
236 papers, 9.2k citations indexed

About

Jeffrey Peppercorn is a scholar working on Oncology, Economics and Econometrics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Jeffrey Peppercorn has authored 236 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Oncology, 71 papers in Economics and Econometrics and 52 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Jeffrey Peppercorn's work include Economic and Financial Impacts of Cancer (59 papers), Health Systems, Economic Evaluations, Quality of Life (53 papers) and Cancer survivorship and care (50 papers). Jeffrey Peppercorn is often cited by papers focused on Economic and Financial Impacts of Cancer (59 papers), Health Systems, Economic Evaluations, Quality of Life (53 papers) and Cancer survivorship and care (50 papers). Jeffrey Peppercorn collaborates with scholars based in United States, Canada and Netherlands. Jeffrey Peppercorn's co-authors include S. Yousuf Zafar, Amy P. Abernethy, Thomas J. Smith, Ethan Basch, Tracy A. Balboni, Sarah Temin, Judith A. Paice, Erin R. Alesi, Betty Ferrell and Ellen Stovall and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Jeffrey Peppercorn

220 papers receiving 8.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Integration of Palliative Care Into Standard Oncology Care: American Society of Clinical Oncology Clinical Practice Guideline Update

2017 1.4k citations Betty Ferrell, Jennifer S. Temel et al. Journal of Clinical Oncology profile →
American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care

2012 950 citations Thomas J. Smith, Sarah Temin et al. Journal of Clinical Oncology profile →
The Financial Toxicity of Cancer Treatment: A Pilot Study Assessing Out-of-Pocket Expenses and the Insured Cancer Patient's Experience

2013 828 citations Jeffrey Peppercorn, Amy P. Abernethy et al. profile →
Web-Based Survey of Fertility Issues in Young Women With Breast Cancer

2004 585 citations Ann H. Partridge, Shari Gelber et al. Journal of Clinical Oncology profile →
American Society of Clinical Oncology Statement: Toward Individualized Care for Patients With Advanced Cancer

2011 388 citations Jeffrey Peppercorn, Thomas J. Smith et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Jeffrey Peppercorn

Since Specialization

Citations

This map shows the geographic impact of Jeffrey Peppercorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey Peppercorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey Peppercorn more than expected).

Fields of papers citing papers by Jeffrey Peppercorn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey Peppercorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey Peppercorn. The network helps show where Jeffrey Peppercorn may publish in the future.

Co-authorship network of co-authors of Jeffrey Peppercorn

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey Peppercorn. A scholar is included among the top collaborators of Jeffrey Peppercorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey Peppercorn. Jeffrey Peppercorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Health Care Utilization and Follow-Up Care in Young Adult Breast Cancer Survivors 2025 ·JCO Oncology Practice ·(unknown), Yue Zheng, Elizabeth Riley, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Steven E. Come, Virginia F. Borges, Ann H. Partridge, Shoshana M. Rosenberg	0
2	Association of Tumor-Infiltrating Lymphocyte Subtypes with Clinical Characteristics and Prognosis in Young Women with Hormone Receptor–Positive Breast Cancer 2025 ·Clinical Cancer Research ·(unknown), Yue Zheng, (unknown), Laura C. Collins, Yujing J. Heng, Nabihah Tayob, Shoshana M. Rosenberg, Kathryn J. Ruddy, Rulla M. Tamimi, Lidia Schapira, Jeffrey Peppercorn, Virginia F. Borges, Steven E. Come, (unknown), Eric P. Winer, Elizabeth A. Mittendorf, Ann H. Partridge	1
3	Effects of Adjuvant Endocrine Therapy–Specific Perceptions on Response to a Behavioral Intervention for Adjuvant Endocrine Therapy Adherence in Patients With Breast Cancer 2024 ·JCO Oncology Practice ·Kelcie Willis, (unknown), (unknown), Kathryn Post, Nora Horick, Michael H. Antoni, Steven A. Safren, Ann H. Partridge, Jeffrey Peppercorn, Elyse R. Park, Jennifer S. Temel, Joseph A. Greer, Jamie M. Jacobs	1
4	The impact of body mass index (BMI) on overall survival (OS) among patients receiving immune checkpoint inhibitors (ICIs): A population-based study. 2024 ·Journal of Clinical Oncology ·(unknown), Rinku Sutradhar, (unknown), (unknown), Yue Niu, Ning Liu, Ying Liu, Melanie Powis, Geoffrey Liu, Jeffrey Peppercorn, Monika K. Krzyzanowska, Lawson Eng	0
5	Breastfeeding experiences among young breast cancer survivors: A survey study 2024 ·Cancer ·Tal Sella, (unknown), Shoshana M. Rosenberg, (unknown), Gregory J. Kirkner, (unknown), Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Ann H. Partridge	3
6	Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors 2023 ·Cancer ·(unknown), Tal Sella, Shoshana M. Rosenberg, (unknown), Gregory J. Kirkner, (unknown), Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Ann H. Partridge	2
7	Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors 2023 ·npj Breast Cancer ·Tal Sella, Yue Zheng, Shoshana M. Rosenberg, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Lisa A. Carey, Eric P. Winer, Ann H. Partridge	3
8	Patient perspectives on testing for clonal hematopoiesis of indeterminate potential 2022 ·Blood Advances ·Tal Sella, Geoffrey Fell, Peter G. Miller, Christopher J. Gibson, Shoshana M. Rosenberg, (unknown), Daniel G. Stover, Kathryn J. Ruddy, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Elizabeth S. Frank, Donna Neuberg, Benjamin L. Ebert, Ann H. Partridge	8
9	Randomized Waitlist-Control Trial of a Web-Based Stress-Management and Resiliency Program for Adolescent and Young Adult Cancer Survivors: Protocol for the Bounce Back Study 2022 ·JMIR Research Protocols ·(unknown), (unknown), Elyse R. Park, Christopher J. Recklitis, Joseph A. Greer, Yuchiao Chang, Natasha N. Frederick, Annah N. Abrams, (unknown), (unknown), Mary Huang, Lisa B. Kenney, (unknown), Karen K. Miller, John W. Denninger, G. Naheed Usmani, Jeffrey Peppercorn, Giselle K. Perez	3
10	Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors 2022 ·Cancer ·Tal Sella, Yue Zheng, (unknown), Shoshana M. Rosenberg, Philip D. Poorvu, Nabihah Tayob, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Lidia Schapira, Steven E. Come, Jeffrey Peppercorn, Virginia F. Borges, Ann H. Partridge, Jennifer A. Ligibel	10
11	Treatment-related amenorrhea in a modern, prospective cohort study of young women with breast cancer 2021 ·npj Breast Cancer ·Philip D. Poorvu, Jiani Hu, Yue Zheng, Shari Gelber, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ellen Warner, Matteo Lambertini, Shoshana M. Rosenberg, Ann H. Partridge	19
12	Impact of fertility concerns on endocrine therapy decisions in young breast cancer survivors 2021 ·Cancer ·Tal Sella, Philip D. Poorvu, Kathryn J. Ruddy, Shari Gelber, Rulla M. Tamimi, Jeffrey Peppercorn, Lidia Schapira, Virginia F. Borges, Steven E. Come, Ann H. Partridge, Shoshana M. Rosenberg	32
13	Trajectories of fear of cancer recurrence in young breast cancer survivors 2021 ·Cancer ·Lidia Schapira, Yue Zheng, Shari Gelber, Philip D. Poorvu, Kathryn J. Ruddy, Rulla M. Tamimi, Jeffrey Peppercorn, Steven E. Come, Virginia F. Borges, Ann H. Partridge, Shoshana M. Rosenberg	69
14	Study protocol for a randomised controlled feasibility trial of a virtual intervention (STRIDE) for symptom management, distress and adherence to adjuvant endocrine therapy after breast cancer 2021 ·BMJ Open ·Jamie M. Jacobs, (unknown), Arielle Horenstein, (unknown), (unknown), Jeffrey Peppercorn, Jennifer S. Temel, Joseph A. Greer	13
15	The Patient’s Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer 2020 ·International Journal of Behavioral Medicine ·Jamie M. Jacobs, (unknown), Elyse R. Park, (unknown), Jeffrey Peppercorn, Ann H. Partridge, Nora Horick, Steven A. Safren, Jennifer S. Temel, Joseph A. Greer	20
16	Perceptions of patients with early stage breast cancer toward research biopsies 2020 ·Cancer ·Davinia Seah, José Pablo Leone, Thomas H. Openshaw, (unknown), Nabihah Tayob, Jiani Hu, Ruth Lederman, Elizabeth S. Frank, Jessica Sohl, Zsofia K. Stadler, (unknown), Stuart G. Silverman, Jeffrey Peppercorn, Eric P. Winer, Steven E. Come, Nancy U. Lin	3
17	Development and Refinement of a Telehealth Intervention for Symptom Management, Distress, and Adherence to Adjuvant Endocrine Therapy after Breast Cancer 2020 ·Journal of Clinical Psychology in Medical Settings ·Jamie M. Jacobs, (unknown), (unknown), Michael H. Antoni, Elyse R. Park, Kathryn Post, Amy Comander, Jeffrey Peppercorn, Steven A. Safren, Jennifer S. Temel, Joseph A. Greer	12
18	FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor–Positive (HR+) Breast Cancer 2019 ·Clinical Cancer Research ·Joshua Z. Drago, Luigi Formisano, Dejan Juric, Andrzej Niemierko, Alberto Servetto, Seth A. Wander, Laura M. Spring, Neelima Vidula, Jerry Younger, Jeffrey Peppercorn, (unknown), (unknown), Dennis C. Sgroi, Steven J. Isakoff, Beverly Moy, Leif W. Ellisen, A. John Iafrate, Carlos L. Arteaga, Aditya Bardia	47
19	Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: A phase II randomized trial 2013 ·Acta Oncologica ·Whitney Hornsby, Pamela S. Douglas, M. West, Aarti A. Kenjale, Amy R. Lane, Emily Schwitzer, (unknown), James E. Herndon, April Coan, Antonio Gutiérrez, (unknown), Erika Hamilton, Lee G. Wilke, Gretchen Kimmick, Jeffrey Peppercorn, Lee W. Jones	156
20	American Society of Clinical Oncology Provisional Clinical Opinion: The Integration of Palliative Care Into Standard Oncology Care breakdown → 2012 ·Journal of Clinical Oncology ·Thomas J. Smith, Sarah Temin, Erin R. Alesi, Amy P. Abernethy, Tracy A. Balboni, Ethan Basch, Betty Ferrell, (unknown), Diane E. Meier, Judith A. Paice, Jeffrey Peppercorn, Mark R. Somerfield, Ellen Stovall, Jamie H. Von Roenn	950

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact